Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review

Date: May 2, 2017
Pages: 62
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IF4D286E4F3EN
Leaflet:

Download PDF Leaflet

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

Apr 26,2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
Apr 04,2017: Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
Feb 23,2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
Dec 07,2016: Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
Dec 05,2016: Integra LifeSciences announces management changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Integra LifeSciences Holdings Corp - Key Facts
Integra LifeSciences Holdings Corp - Key Employees
Integra LifeSciences Holdings Corp - Key Employee Biographies
Integra LifeSciences Holdings Corp - Major Products and Services
Integra LifeSciences Holdings Corp - Medical Equipment Pipeline Products Data
Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type
Integra LifeSciences Holdings Corp Pipeline Products by Development Stage
Integra LifeSciences Holdings Corp - History
Integra LifeSciences Holdings Corp - Company Statement
Integra LifeSciences Holdings Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Integra LifeSciences Holdings Corp - Business Description
Business Description - Orthopedics and Tissue Technologies
Orthopedics and Tissue Technologies - Overview
Orthopedics and Tissue Technologies - Financials
Business Description - Specialty Surgical Solutions
Specialty Surgical Solutions - Overview
Specialty Surgical Solutions - Financials
Integra LifeSciences Holdings Corp - Corporate Strategy
Integra LifeSciences Holdings Corp - SWOT Analysis
SWOT Analysis - Overview
Integra LifeSciences Holdings Corp - Strengths
Integra LifeSciences Holdings Corp - Weaknesses
Integra LifeSciences Holdings Corp - Opportunities
Integra LifeSciences Holdings Corp - Threats
Integra LifeSciences Holdings Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
Integra LifeSciences Holdings Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 04, 2017: Integra LifeSciences Announces Expansion of Credit Facility to include new $700 million term loan
Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
Dec 07, 2016: Integra LifeSciences Announces Expansion and Extension of Credit Facility to $1.5 Billion
Dec 05, 2016: Integra LifeSciences announces management changes
Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments
Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results
Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results
Jun 16, 2016: Integra LifeSciences to Hold First International Tissue Technologies Symposium on June 16 - 17, 2016 in Lisbon, Portugal
Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results
Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Integra LifeSciences Holdings Corp, Key Facts
Integra LifeSciences Holdings Corp, Key Employees
Integra LifeSciences Holdings Corp, Key Employee Biographies
Integra LifeSciences Holdings Corp, Major Products and Services
Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type
Integra LifeSciences Holdings Corp Number of Pipeline Products by Development Stage
Integra LifeSciences Holdings Corp Pipeline Products Summary by Development Stage
Integra LifeSciences Holdings Corp, History
Integra LifeSciences Holdings Corp, Other Locations
Integra LifeSciences Holdings Corp, Subsidiaries
Integra LifeSciences Holdings Corp, Key Competitors
Integra LifeSciences Holdings Corp, Ratios based on current share price
Integra LifeSciences Holdings Corp, Annual Ratios
Integra LifeSciences Holdings Corp, Annual Ratios (Cont.1)
Integra LifeSciences Holdings Corp, Annual Ratios (Cont.2)
Integra LifeSciences Holdings Corp, Interim Ratios
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
Integra LifeSciences Holdings Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Integra LifeSciences Holdings Corp Pipeline Products by Equipment Type
Integra LifeSciences Holdings Corp Pipeline Products by Development Stage
Integra LifeSciences Holdings Corp, Performance Chart (2012 - 2016)
Integra LifeSciences Holdings Corp, Ratio Charts
Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Zimmer Biomet Holdings Inc
Wright Medical Group NV
Stryker Corporation
Smith & Nephew Plc
MiMedx Group Inc
Medtronic Plc
Johnson & Johnson
C. R. Bard Inc
Becton Dickinson and Co
Acelity L.P. Inc.
Skip to top


Ask Your Question

Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: